Mathematica is continuously monitoring this fluid situation, and we are proactively working to minimize any potential impacts on our clients, partners, staff, and the important work that we do together. Learn more.
- Health program and policy evaluation
- Qualitative research methods
- Health information technology
- Learning health systems
- Delivery System Reforms
- Health Information Technology and Analytics
- Population Health
- Quality Improvement
Danielle Whicher is a health services researcher and health policy professional with expertise in learning health systems, health information technology, health system delivery and financing reform, and bioethics. She specializes in qualitative research evaluations, policy research, and stakeholder engagement.
Whicher, who joined Mathematica in 2019, is part of the implementation teams for several large-scale evaluations of national and state health payment and delivery reform initiatives. She is also engaged in efforts to evaluate health information technologies and health system performance. In her previous role at the National Academy of Medicine (NAM), she completed several policy projects on the topics of leveraging artificial intelligence to improve health and health care; health data sharing, linkage, and use to support learning health systems; and treatment heterogeneity and personalized medicine. Whicher has also participated in a number of qualitative research projects designed to understand stakeholder perspectives on complex bioethics issues and policy options.
Before her work at NAM, Whicher held positions at the Patient-Centered Outcomes Research Institute, the Johns Hopkins Berman Institute for Bioethics, and the Center for Medical Technology Policy. She has a Ph.D. and M.H.S in health policy and management from the Johns Hopkins Bloomberg School of Public Health and currently serves as a coeditor for the journal Value in Health. Her work has been published in a variety of reports and peer-reviewed journals, including Annals of Internal Medicine, Medical Care, PharmacoEconomics, Clinical Trials, and The Journal of Law, Medicine, & Ethics.